all report title image

ANTACID MEDICATIONS MARKET ANALYSIS

Antacid Medications Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI91
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market News

Key Developments

  1. Key players in the market are involved in various business strategies such as product acquisition, in order to expand their product portfolio. For instance, in June 2017, Pfizer India acquired AstraZeneca, a Swedish pharmaceutical firm’s Nekasium, a drug used as antacid. Nekasium was launched in India in 2006 and has been recommended by doctors to reduced hyperacidity.
  2. Major players in the market are involved in various business strategies such as product launches, in order to expand their product portfolio. For instance, in May 2017, GSK Consumer Healthcare launched ‘ENO Cooling’. It is an antacid sold in powered form in sachets, which offers instant relief against acidity.
  3. Key players in the market are involved in various business strategies such as product launches, in order to expand their product portfolio and enhance the market presence. For instance, in October 2018, Dr. Reddy’s Laboratories launched ‘Omeprazole’ delayed-release tablets in the U.S. market, which can be used for frequent heartburn issues.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.